Cargando…
β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers
NQO1 is a FAD-binding protein that can form homodimers and reduce quinones to hydroquinones, and a growing body of evidence currently suggests that NQO1 is dramatically elevated in solid cancers. Here, we demonstrated that NQO1 was elevated in breast cancer and that its expression level was positive...
Autores principales: | Yang, Yang, Zhou, Xianchun, Xu, Ming, Piao, Junjie, Zhang, Yuan, Lin, Zhenhua, Chen, Liyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457413/ https://www.ncbi.nlm.nih.gov/pubmed/28578385 http://dx.doi.org/10.1038/s41598-017-02937-0 |
Ejemplares similares
-
NQO1 is Required for β-Lapachone-Mediated Downregulation of Breast-Cancer Stem-Cell Activity
por: Kim, Dong Wook, et al.
Publicado: (2018) -
Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition
por: Kong, Jienan, et al.
Publicado: (2016) -
β-lapachone ameliorates murine cisplatin nephrotoxicty – NAD+, NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation
por: Lu, Christopher Y.
Publicado: (2014) -
β-Lapachone Induces Acute Oxidative Stress in Rat Primary Astrocyte Cultures that is Terminated by the NQO1-Inhibitor Dicoumarol
por: Steinmeier, Johann, et al.
Publicado: (2020) -
Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis
por: Gerber, David E., et al.
Publicado: (2018)